发明名称 MATRIX MATALLOPROTEASE INHIBITORS
摘要 <p>Compounds of the formula: <CHEM> wherein: n is 0, 1 or 2; Y is hydroxy or XONH-, where X is hydrogen or lower alkyl; R<1> is hydrogen or lower alkyl; R<2> is hydrogen, lower alkyl, heteroalkyl, aryl, aralkyl, arylheteroalkyl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroaralkyl, heteroarylheteroalkyl, heterocyclo, heterocylo-lower alkyl, heterocyclo-lower heteroalkyl or -NR<6>R<7>, wherein: R<6> is hydrogen, lower alkyl, cycloalkyl or cycloalkylalkyl, aryl, heteroaryl and heteroaralkyl; R<7> is hydrogen, lower alkyl, cycloalkyl or cycloalkylalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, -C(O)R<8>, -C(O)NR<8>R<9>, -SO2NR<8>R<9>, -SO2R<10>, aryloxycarbonyl, or alkoxycarbonyl; or R<6> and R<7> together with the nitrogen atom to which they are attached represent a heterocyclo group; wherein R<8> and R<9> are independently hydrogen, lower alkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl or heteroalkyl; and R<10> is lower alkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, heteroalkyl or heterocyclo; or R<1> and R<2> together with the carbon atom to which they are attached represent a cycloalkyl or heterocyclo group; R<3> is hydrogen, lower alkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, heteroalkyl or lower alkoxy; R<4> is hydrogen, lower alkyl, cycloalkyl or cycloalkylalkyl; or R<2> and R<3> together with the carbons to which they are attached represent a cycloalkyl or heterocyclo group; or R<3> and R<4> together with the carbon to which they are attached represent a cycloalkyl or heterocyclo group; and R<5> is lower alkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heteroaryl, or heteroaralkyl; or pharmaceutically acceptable salts or esters thereof exhibit useful pharmacological properties, in particular for use as matrix metalloprotease inhibitors, particularly for interstitial collagenases.</p>
申请公布号 CZ9603740(A3) 申请公布日期 1998.01.14
申请号 CZ19960003740 申请日期 1996.12.18
申请人 F. HOFFMANN - LA ROCHE AG;AGOURON PHARMACEUTICALS 发明人 BENDER STEVEN LEE;BROKA CHRIS ALLEN;CAMPBELL JEFFREY ALLEN;CASTELHANO ARLINDO LUCAS;HENDRICKS ROBERT THAN;SARMA KESHAB;FISHER LAWRENCE EMERSON
分类号 C07D333/34;A61K31/00;A61K31/10;A61K31/165;A61K31/18;A61K31/185;A61K31/34;A61K31/341;A61K31/35;A61K31/351;A61K31/38;A61K31/381;A61K31/382;A61K31/44;A61K31/4402;A61K31/4427;A61K31/4433;A61K31/445;A61K31/4465;A61P1/00;A61P1/02;A61P3/00;A61P5/00;A61P19/00;A61P19/10;A61P27/00;A61P27/02;A61P29/00;A61P35/00;A61P43/00;C07C259/06;C07C315/02;C07C317/44;C07C323/51;C07D211/54;C07D213/64;C07D213/643;C07D307/14;C07D309/08;C07D335/02;C07D401/04;C07D401/06;C07D405/12;C07D407/12;C07D409/12;C07D413/12;(IPC1-7):C07D213/02;C07D211/36;C07D405/02;A61K31/535 主分类号 C07D333/34
代理机构 代理人
主权项
地址